This is with reference to your email dated 15th April, 2026 and Letter No. L/SURV/ONL/PV/APJ/ 2026-2027 / 3730 received from BSE seeking clarification regarding the significant movement in price of the share price of the company. In this regards, we wish to inform you that all the material information/announcement that may have bearing on the operations/performance of the Company which includes all the necessary disclosures in accordance with regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and under insider trading regulation, have always been disclosed by the Company within the stipulated time. There is no pending information or announcement which have a bearing on price movement of the Company. Therefore, The movement in Company''s share price is purely due to market conditions and are market driven on which the Company neither has any control nor has any knowledge of reasons.
Reply to the clarification sought on price movement
View original source (BSE India)Trident Texofab Ltd. on 6ix
Earlier from Trident Texofab
- Trident Texofab Ltd. Press Release Apr 08 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Trident Texofab Ltd. Press Release Mar 30 2026
- Closure of Trading Window
- Trident Texofab Ltd. Press Release Mar 27 2026
Later from Trident Texofab
- Trident Texofab Ltd. Press Release Apr 30 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held On 30.05.2026
- Result- Financial Result For Quarter And Year Ended 31.03.2026
- Trident Texofab Ltd. Press Release May 30 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab